Business Wire

KLAS report: InterSystems TrakCare Tops Global EMR Deployments

Del

The electronic medical record (EMR) technology from InterSystems has been deployed by more hospitals than any other vendor’s software during the past four years, according to a research report published today by the internationally recognized research organization KLAS. InterSystems TrakCare®, a unified healthcare information system, has ‘pulled ahead’ of its competitors as a preferred solution, winning significantly more new hospitals globally (non US) than any other supplier in 2016, the report found.

The influential report examines new hospital EMR contracts worldwide, outside of the United States, and found a significant increase in EMR purchasing decisions across the globe in 2016, with TrakCare being a market leader in new hospital wins. Detailing 56 total hospital wins for InterSystems in 2016, the report acknowledged a lower all-in-cost and high proportion of multi-facility contracts for InterSystems customers.

“Broad functionality and a light IT footprint have led to InterSystems being deployed by more hospitals over the past four years than any other solution,” the report said. “InterSystems’ strong 2016 across Europe, Asia, and the Middle East – which included new contracts with several multihospital organizations in the UK and China – was driven by an all-in cost lower than Cerner’s and Epic’s.”

“InterSystems is working with some of the world’s most digitally progressive healthcare providers, who are using TrakCare to improve care and empower clinicians with clinically advanced IT solutions,” said Christine Chapman, vice president for TrakCare at InterSystems. “The success speaks to our commitment to patients and providers alike, our proven ability to deliver value for customers in diverse countries, and a growing need for solutions that respond to the needs of different care settings.”

Highlights from the report included:

  • Hospitals wanting a “good mix of functionality with a lower all-in price” during the past three to four years “deployed or chose to deploy InterSystems more than any other vendor.”
  • InterSystems contracts represented the highest total number of inpatient facilities, thanks to decisions by multi-site customers such as a public health board in Scotland, a private maternity group in China, and a private hospital group in England.
  • InterSystems was reported to be “winning in the UK,” where healthcare providers were said to prefer InterSystems to UK-specific alternatives, and that despite financing challenges faced in the country, providers finalized several EMR contracts. InterSystems “far and away had the most new hospitals associated to these contracts,” the report said, highlighting signings with a health board in Scotland, a large private hospital group and a consortium of NHS trusts.
  • InterSystems is the only vendor featured in the report to have clients in China and Thailand

on their “go-forward solution” with the corporation expanding presence in both countries in 2016 – including a group of maternity hospitals in China and a well-known private hospital in Thailand.

  • The report described InterSystems’ expansion in Asia and market presence in Europe and the Middle East, with commentary highlighting new InterSystems contracts in countries including Italy and France and with a hospital group in the United Arab Emirates.

For more information on the KLAS report visit KLAS online at www.klasresearch.com.

About KLAS

KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment and infrastructure systems to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving supplier performance. KLAS was founded in 1996, and their staff and advisory board average 25 years of healthcare information technology experience. Follow KLAS on Twitter at www.twitter.com/KLASresearch.

About InterSystems

InterSystems is the engine behind the world’s most important applications. In healthcare, finance, government, and other sectors where lives and livelihoods are at stake, InterSystems is the power behind what mattersTM. Founded in 1978, InterSystems is a privately held company headquartered in Cambridge, Massachusetts (USA), with offices worldwide, and its software products are used daily by millions of people in more than 80 countries. For more information, visit InterSystems.com.

Contact information

Media Contact:
InterSystems
Tom Keppeler, +617-551-2116
Tom.Keppeler@intersystems.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Pharnext: First-Half 201719.10.2017 17:30Pressemelding

Regulatory News: Pharnext SA (FR00111911287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drugs based on the combination and repositioning of known drugs, today announced its first-half 2017 financial results. Daniel Cohen, M.D., Ph.D. Co-Founder and CEO said of activity for the first half of 2017: "Activity in the first-half of the year was very dense; we implemented two prominent strategic partnerships with the biotech company Galapagos and the Tasly Group, one of the top ten pharmaceutical companies in China. Our flagship product, PXT3003 for the treatment of Charcot-Marie-Tooth disease type 1A, is nearing the end of Phase 3, which is slated for the second half of 2018. We confirm our target of taking the product to market by 2019." A half-year marked by strategic agreements

Tickets Now on Sale for FEI World Equestrian Games Tryon 2018, North Carolina, USA, on September 11-23, 201819.10.2017 16:58Pressemelding

Tickets for the FEI World Equestrian GamesTM Tryon 2018 (WEG) are now on sale to the public online at www.tryon2018.com. With more than 500,000 people expected to attend the 2018 Games, the 12-day spectacle of equestrian champions is one of the biggest events on the global sporting calendar and will be the largest equestrian event in North Carolina’s history. Mark Bellissimo, CEO of host venue Tryon International Equestrian Center (TIEC) in Tryon, NC, USA, said: “Demand from the event is way beyond our expectations and it would not surprise me if this event were to sell out early. We have experienced unprecedented demand, far bigger than we ever anticipated. There is tremendous appetite for this event, so we encourage people to buy now.” Tickets for the WEG include the following options: a standard Day Pass, Individual Event Pass, All Session Discipline Pas

AMRA and BioTelemetry Research Raise the Standard for Medical Imaging in NASH/NAFLD Clinical Trials19.10.2017 16:04Pressemelding

AMRA, the international leader in body composition analysis, and BioTelemetry Research (“BTR”), a leading global imaging and cardiac core lab, announced today the formation of an exclusive alliance for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) clinical trials. This first-to-market partnership will advance imaging science and benefit clinical trial sponsors in several musculoskeletal and metabolic therapeutic areas. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171019006110/en/ In clinical studies, muscle and fat fractions have traditionally been measured by scanning individual organs such as the liver, or particular body regions such as the abdomen. Commonly, researchers would prefer to scan the entire body in order to learn exactly where study participants are losing or gaining mu

AGCO Announces a New Data Connection with The Climate Corporation’s Climate FieldViewTM Digital Agriculture Platform19.10.2017 14:30Pressemelding

AGCO Corporation (NYSE:AGCO), a world-leading manufacturer and distributor of agricultural equipment, announced today a new digital partnership with The Climate Corporation, a subsidiary of Monsanto Company (NYSE:MON), that will provide AGCO customers the option to connect with The Climate Corporation’s Climate FieldView™ platform. AGCO’s partnership with The Climate Corporation is a product of Fuse and its open approach to agriculture, which focuses on helping customers optimize their farms through seamless technology integration and connectivity. “AGCO is excited to work with The Climate Corporation to give our customers yet another choice for Precision Ag solutions,” says Chris Rhodes, director Fuse Business Development. “The Climate FieldView platform is the world’s most broadly connected and adopted farm insight and visualization platform, and AGCO is pleased to be creating a tigh

Arrive Safely: Head to Tirendo and Equip Yourself Properly for Your First Winter19.10.2017 14:25Pressemelding

The days are getting shorter, and the thermometer is dropping. Especially for new drivers looking forward to their first winter behind the wheel, the sudden onset of snowy and icy roads can be a real challenge. Even more important, therefore, to make sure that you have the appropriate tyres for wintry driving conditions. Tirendo shares some tips on what this involves. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171019005888/en/ Head to Tirendo and equip yourself properly for your first winter - Photo source: ENZO In winter weather above all, the correct tread depth is crucial for safe driving. The legal minimum throughout Europe is 1.6 mm, however experts recommend at least 4 mm in snowy and icy conditions to ensure sufficient grip. To measure your tyre’s tread depth, simply take a two euro coin:

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom